Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Sep 3;115(35-36):598.
doi: 10.3238/arztebl.2018.0598a.

Centrifugal Surgery

Maria Gaiser, Jochen Utikal
Comment

Centrifugal Surgery

Maria Gaiser et al. Dtsch Arztebl Int. .
No abstract available

PubMed Disclaimer

Comment in

  • In Reply.
    Kupilas FJ, Kleinheinz J. Kupilas FJ, et al. Dtsch Arztebl Int. 2018 Sep 3;115(35-36):598. doi: 10.3238/arztebl.2018.0598b. Dtsch Arztebl Int. 2018. PMID: 30236226 Free PMC article. No abstract available.

Comment on

  • The Consequences of a "Harmless" Frontal Swelling.
    Kupilas FJ, Kleinheinz J, LastName FM. Kupilas FJ, et al. Dtsch Arztebl Int. 2018 May 11;115(19):344. doi: 10.3238/arztebl.2018.0344. Dtsch Arztebl Int. 2018. PMID: 29875060 Free PMC article. No abstract available.

References

    1. Kupilas FJ, Kleinheinz J. The consequences of a harmless frontal swelling. Dtsch Arztebl Int. 2018;115 - PMC - PubMed
    1. McArthur GA, Demetri GD, van Oosterom A, et al. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol. 2005;23:866–873. - PubMed
    1. Rutkowski P, van Glabbeke M, Rankin CJ, et al. Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials. J Clin Oncol. 2010;28:1772–1779. - PMC - PubMed
    1. Urgurel S, Mentzel T, Utikal J, et al. Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up. Clin Cancer Res. 2014;20:499–510. - PubMed